http://www.drugdiscoverynews.com/index.php?newsarticle=6128
This is DEFINITELY one to read...
Paradigm shift: Rethinking type 2 diabetes as a heterogeneous disease
by Dr. Steven R. Smith, TRI
"I believe the primary reason we aren’t effectively treating diabetes today is because our current understanding of this disease is quite rudimentary. Our lack of awareness and appreciation about the inherent complexity and heterogeneity of diabetes has confined us to a one-size-fits-all paradigm for managing this disease. For millions of patients, this approach is simply not working.
"Our current methodology of trial-and-error drug development and prescribing is neither prudent nor sustainable—and its days are numbered....."
This is DEFINITELY one to read...
Paradigm shift: Rethinking type 2 diabetes as a heterogeneous disease
by Dr. Steven R. Smith, TRI
"I believe the primary reason we aren’t effectively treating diabetes today is because our current understanding of this disease is quite rudimentary. Our lack of awareness and appreciation about the inherent complexity and heterogeneity of diabetes has confined us to a one-size-fits-all paradigm for managing this disease. For millions of patients, this approach is simply not working.
"Our current methodology of trial-and-error drug development and prescribing is neither prudent nor sustainable—and its days are numbered....."